- Home
- API vs LFCR Comparison
API vs LFCR Comparison
Compare API & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- API
- LFCR
- Stock Information
- Founded
- API 2013
- LFCR 1986
- Country
- API United States
- LFCR United States
- Employees
- API N/A
- LFCR N/A
- Industry
- API Computer Software: Prepackaged Software
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- API Technology
- LFCR Health Care
- Exchange
- API Nasdaq
- LFCR Nasdaq
- Market Cap
- API 346.0M
- LFCR 308.8M
- IPO Year
- API 2020
- LFCR N/A
- Fundamental
- Price
- API $4.00
- LFCR $7.43
- Analyst Decision
- API Strong Buy
- LFCR Buy
- Analyst Count
- API 1
- LFCR 4
- Target Price
- API $6.00
- LFCR $8.00
- AVG Volume (30 Days)
- API 389.6K
- LFCR 199.1K
- Earning Date
- API 08-18-2025
- LFCR 08-25-2025
- Dividend Yield
- API N/A
- LFCR N/A
- EPS Growth
- API N/A
- LFCR N/A
- EPS
- API N/A
- LFCR N/A
- Revenue
- API $133,504,000.00
- LFCR $130,309,000.00
- Revenue This Year
- API $7.10
- LFCR $1.64
- Revenue Next Year
- API $10.91
- LFCR $2.91
- P/E Ratio
- API N/A
- LFCR N/A
- Revenue Growth
- API N/A
- LFCR 7.23
- 52 Week Low
- API $1.65
- LFCR $3.68
- 52 Week High
- API $6.99
- LFCR $8.85
- Technical
- Relative Strength Index (RSI)
- API 54.54
- LFCR 45.13
- Support Level
- API $3.95
- LFCR $7.39
- Resistance Level
- API $4.20
- LFCR $7.67
- Average True Range (ATR)
- API 0.19
- LFCR 0.35
- MACD
- API 0.00
- LFCR -0.12
- Stochastic Oscillator
- API 44.33
- LFCR 7.19
About API Agora Inc.
Agora Inc provides real-time communication solutions. The company offers real-time video calling, voice calling, live audio and video streaming, recording, and real-time messaging. It serves the gaming, retail, and education industries. The company operates in the People's Republic of China and the United States of America and the majority of its revenue is derived from the People's Republic of China.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.